Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 1
1990 2
1991 2
1993 1
1994 3
1995 3
1996 2
1998 2
1999 3
2000 7
2001 5
2002 2
2003 1
2005 1
2006 1
2007 3
2008 5
2009 9
2010 2
2011 6
2012 1
2013 4
2014 4
2015 5
2016 1
2017 3
2018 4
2019 4
2020 6
2021 6
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

94 results
Results by year
Filters applied: . Clear all
Page 1
Animal models for COVID-19.
Muñoz-Fontela C, Dowling WE, Funnell SGP, Gsell PS, Riveros-Balta AX, Albrecht RA, Andersen H, Baric RS, Carroll MW, Cavaleri M, Qin C, Crozier I, Dallmeier K, de Waal L, de Wit E, Delang L, Dohm E, Duprex WP, Falzarano D, Finch CL, Frieman MB, Graham BS, Gralinski LE, Guilfoyle K, Haagmans BL, Hamilton GA, Hartman AL, Herfst S, Kaptein SJF, Klimstra WB, Knezevic I, Krause PR, Kuhn JH, Le Grand R, Lewis MG, Liu WC, Maisonnasse P, McElroy AK, Munster V, Oreshkova N, Rasmussen AL, Rocha-Pereira J, Rockx B, Rodríguez E, Rogers TF, Salguero FJ, Schotsaert M, Stittelaar KJ, Thibaut HJ, Tseng CT, Vergara-Alert J, Beer M, Brasel T, Chan JFW, García-Sastre A, Neyts J, Perlman S, Reed DS, Richt JA, Roy CJ, Segalés J, Vasan SS, Henao-Restrepo AM, Barouch DH. Muñoz-Fontela C, et al. Among authors: krause pr. Nature. 2020 Oct;586(7830):509-515. doi: 10.1038/s41586-020-2787-6. Epub 2020 Sep 23. Nature. 2020. PMID: 32967005 Free PMC article. Review.
Considerations in boosting COVID-19 vaccine immune responses.
Krause PR, Fleming TR, Peto R, Longini IM, Figueroa JP, Sterne JAC, Cravioto A, Rees H, Higgins JPT, Boutron I, Pan H, Gruber MF, Arora N, Kazi F, Gaspar R, Swaminathan S, Ryan MJ, Henao-Restrepo AM. Krause PR, et al. Lancet. 2021 Oct 9;398(10308):1377-1380. doi: 10.1016/S0140-6736(21)02046-8. Epub 2021 Sep 14. Lancet. 2021. PMID: 34534516 Free PMC article. Review. No abstract available.
SARS-CoV-2 Variants and Vaccines.
Krause PR, Fleming TR, Longini IM, Peto R, Briand S, Heymann DL, Beral V, Snape MD, Rees H, Ropero AM, Balicer RD, Cramer JP, Muñoz-Fontela C, Gruber M, Gaspar R, Singh JA, Subbarao K, Van Kerkhove MD, Swaminathan S, Ryan MJ, Henao-Restrepo AM. Krause PR, et al. N Engl J Med. 2021 Jul 8;385(2):179-186. doi: 10.1056/NEJMsr2105280. Epub 2021 Jun 23. N Engl J Med. 2021. PMID: 34161052 Free PMC article.
COVID-19 vaccine trials: The potential for "hybrid" analyses.
Fleming TR, Nason M, Krause PR, Longini IM, Henao-Restrepo AM. Fleming TR, et al. Among authors: krause pr. Clin Trials. 2021 Aug;18(4):391-397. doi: 10.1177/17407745211018613. Epub 2021 May 27. Clin Trials. 2021. PMID: 34041932 Free PMC article.
Immunology of protection from Ebola virus infection.
Krause PR, Bryant PR, Clark T, Dempsey W, Henchal E, Michael NL, Regules JA, Gruber MF. Krause PR, et al. Sci Transl Med. 2015 May 6;7(286):286ps11. doi: 10.1126/scitranslmed.aaa8202. Sci Transl Med. 2015. PMID: 25947159 Review.
Priorities for CMV vaccine development.
Krause PR, Bialek SR, Boppana SB, Griffiths PD, Laughlin CA, Ljungman P, Mocarski ES, Pass RF, Read JS, Schleiss MR, Plotkin SA. Krause PR, et al. Vaccine. 2013 Dec 17;32(1):4-10. doi: 10.1016/j.vaccine.2013.09.042. Epub 2013 Oct 13. Vaccine. 2013. PMID: 24129123 Free PMC article. Review.
Evaluating human trials: FDA's role.
Krause PR, Gruber MF. Krause PR, et al. Science. 2018 Jun 22;360(6395):1308. doi: 10.1126/science.aau0591. Epub 2018 Jun 21. Science. 2018. PMID: 29930128 No abstract available.
Stability evaluation of vaccines.
Schofield T, Krause PR. Schofield T, et al. Among authors: krause pr. Biologicals. 2009 Nov;37(6):355. doi: 10.1016/j.biologicals.2009.09.001. Epub 2009 Sep 26. Biologicals. 2009. PMID: 19783158 No abstract available.
94 results